IL6 and triple-negative breast carcinoma: We were able to replicate our in vivo results in vitro, whereby chronic osteoblast treatment with the conditioned media of triple-negative breast cancer cells resulted in osteoblasts that express osteopontin, but have reduced IL-6 and alpha-SMA protein expression (Fig. 2).